Abstract
The biological effectiveness of low energy transfer (LET) ionizing radiation is in part related to the amount of oxygen present at the time of the energy deposit. This dose modifying role of oxygen (oxygen enhancement ratio) is principally caused by the indirect effect ofradiation on DNA (1,2). Hypoxic cells are present in rodent and xenografted human tumors, and it has been known for a long time that the absence ofoxygen in tumors is a factor ofresistance against ionizing radiation (3–5). More recently, it has been shown that the decrease in tumor oxygen tension could also be a factor ofresistance for treatment with some cytotoxic drugs (6–8), not only directly through the low-oxygen partial pressures, but indirectly through modifications in some gene expression by O2 and other environmental factors (vascularization, pH, metabolism, angiogenic factors, and so on) (9,10). In patients, tumors are known to contain hypoxic areas (11–14), and the local control of human solid tumors could be improved if a clinically relevant test was able to identify tumors that would benefit from radiosensitization (5). Oxygen availability is dependent on oxygen supply, which depends on many parameters: microvasculature, blood flow, tissue temperature, and pH (15,16). Tissue oxygenation will result directly from 02 availability, and from the respiration rate ofthe cells. For normal tissues, changes in oxygenation reflect variations in blood flow, and partial oxygen pressure (pO2) distribution has been evaluated as a function of hemoglobin concentration, temperature, pH, and so on (15). In tumors, tissue vascularization is qualitatively poor with shunts, vessel collapses, and high interstitial pressure. All these parameters may represent a potential therapeutic target (16–18).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kellerer, A. M. and Rossi, H. H. (1971) RBE and the primary mechanism of radiation action. Radiat. Res. 47, 15–34.
Biaglow, J. E. (1981) Effects of ionizing radiation on mammalian cells. J. Chem. Educ. 58, 144–156.
Thomlinson, R. H. and Gray, L. H. (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539–549.
Bush, R. S., Jenkin, R. D. T., Allt, W. E. C., Beale, F. A., Bean, H., Dembo, A. J., and Pringle, J. F. (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br. J. Cancer 37(Suppl. III), 302–306.
Overgaard, J. (1991) Importance of tumor hypoxia in radiotherapy. A meta-analysis of controlled clinical trials. Radiother. Oncol. 24, S64.
Teicher, B. A., Lazo, J. S., and Sartorelli, A. C. (1981) Classification of antineoplasic agents by their selective toxicities towards oxygenated and hypoxic tumor cell. Cancer Res. 41, 73–81.
Kennedy, K. A. (1987) Hypoxic cells as specific drug targets for chemotherapy. Anticancer Drug Res. 2, 181–194.
Sakata, K., Tak Kwok, T., Murphy, B. J., Laderoute, K. R., Gordon, G. R., and Sutherland, R. M. (1991) Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br. J. Cancer 64, 809–814.
Sutherland, R. M., Ausserer, W. A., Murphy, B. J., and Laderoute, K. R. (1996) Tumour hypoxia and heterogeneity: challenges and opportunities for the future. Sem. Radiat. Oncol. 6, 59–70.
Giaccia, A. J. (1996) Hypoxic stress proteins: survival of the fittest. Sem. Radiat. Oncol. 6, 46–58.
Guichard, M. (1990) Comparison of the radiobiological properties of human tumor xenografts and rodent tumors. Int. J. Radiat. Biol. 56, 583–586.
Rockwell, S. and Moulder, J. E. (1990) Hypoxic fractions of human tumors xenografted into mice: a review. Int. J. Radiat. Oncol. Biol. Phys. 19, 197–202.
Chapman, J. D. (1991) Measurement of tumor hypoxia by invasive and noninvasive procedures: a review of recent clinical studies. Radiother. Oncol. 20, 13–19.
Coleman, C. N. (1988) Hypoxia in tumors: aparadigm for the approach to biochemical and physiological heterogeneity. J. Natl. Cancer. Inst. 80, 310–316.
Vaupel, P., Kallinowski, F., and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic environment of human tumors: a review. Cancer Res. 49, 6449–6465.
Jain, R. K. (1988) Determinants of tumor blood flow: a review. Cancer Res. 48, 2641–2658.
Chaplin, D. J., Durand, R. E., and Olive, P. L. (1986) Acute hypoxia in tumors: implications for modifiers of radiation effects. Int. J. Radiat. Oncol. Biol. Phys. 12, 1091–1095.
Hirst, G. H. (1986) Anemia: a problem or an opportunity in radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 12, 2009–2017.
Vaupel, P. W., ed. (1994) Blood Flow, Oxygenation, Tissue pH Distribution, and Bioenergetic Status of Tumours. Ernst Schering Research Foundation, Berlin.
Milross, C. G., Peters, L. J., Hunter, N. R., Mason, K. A., Tucker, S. L., and Milas, L. (1996) Polarographic pO2 in mice: effect of tumor type, site of implantation and anesthesia. Radiat. Oncol. Invest. 4, 108–114.
Milross, C. G., Tucker, S. L., Mason, K. A., Hunter, N. R., Peters, L. J., and Milas, L. (1997) Effect of tumour size on necrosis and polarographically measured pO2. Acta Oncol. 36, 183–189.
Davies, P. W. and Brink, F. (1946) Microelectrodes formeasuring local oxygen tension in animal tissues. Rev. Sci. Instrum. 13, 524–533.
Vanderkooi, J. M., Erecinska, M., and Silver, I. A. (1991) Oxygen in mammalian tissue: methods of measurement and affinities of various reactions. Am. J. Physiol. 260(Cell Physiol. 29), C 1131–C 1150.
Chou, S-C., Flood, P. M., and Raleigh, J. A. (1996) Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole. Br. J. Cancer 74(Suppl. XXVII), S213–S216.
Matthews, J., Adomat, H., Farrell, N., et al. (1996) Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5. Br. J. Cancer 74(Suppl. XXVII), S200–S203.
Chapman, J. D. Coia, L. R., Stobbe, C. C., Engelhardt, E. L., Fenning, M. C., and Schneider, R. F. (1996) Prediction of tumour hypoxia and radioresistance with nuclear medecine markers.Br. J. Cancer 74, (Suppl. XXVII) S204–S208.
Guichard, M., Lartigau, E., Tinet, E., Thomas, C., and Avrillier, S. (1997) Suivi non invasifde l’evolution de 1’oxygenation des tumeurs par réflectivité différentielle. J. Optics 28, 265–269.
Young, W. K., Vojnovic, B., and Wardman, P. (1996) Measurement of oxygen tension in tumours by
time-resolved fluorescence. Br. J. Cancer 74(Suppl. XXVII), S256–S259. 29. Olive, P. L., Viske, C. M., and Durand, R. E. (1994) Hypoxic fractions measured in murine tumors and normal tissues using the comet assay. Int. J. Radiat. Oncol. Biol. Phys. 29, 487–491.
Urtasun, R. C., Parliament, M. B., McEwan, A. J., Mercer, J. R., Mannan, R. H., Wiebe, L. I., Morin, C., and Chapman, J. D. (1996) Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. Br. J. Cancer 74(Suppl. XXVII), S209–S212.
McCoy, C. L., McIntyre, D. J. O., Robinson, S. P., Aboagye, E. O., and Griffiths, J. R. (1996) Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation. Br. J. Cancer 74(Suppl. XXVII), S226–S231.
Stone, H. B., Brown, J. M., Philips, T. L., and Sutherland, R. M. (1993) Oxygen in human tumors: correlation between methods of measurements and response to therapy. Radiat. Res. 136, 422–434.
Cater, D. B. and Silver, I. A. (1960) Quantitative measurements of oxygen tension in normal tissues and in the tumors of patients before and after radiotherapy. Acta Radiol. 53, 233–256.
Kolstad, P. (1968) Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand. J. Clin. Lab. Invt. 106(Suppl.), 145–157.
Bergsjo, P. and Evans, J. C. (1968) Oxygen tension of cervical carcinoma during the early phase of external irradiation. Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of the cervix. Scand. J. Clin. Lab. Inv. 106(Suppl.), 167–171.
Badib, A. O. and Webster, J. H. (1969) Changes in tumor oxygen tension during radiation therapy. Acta Radiol. Ther. Phys. Biol. 8, 247–257.
Gatenby, R. A., Coia, L. R., Richter, M. P., Katz, H., Moldofsky, P. J., and Engstrom, P. (1985) Oxygen tension in human tumors: in vivo mapping using CT-guided probes. Radiology 156, 211–214.
Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Modofsky, P. J., Hart, W. H., and Broder, G. J. (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 10, 831–838.
Pappova, N., Siracka, E., Vacek, A., and Durkovsky, J. (1982) Oxygen tension and prediction of the radiation response. Polarographic study in human breast cancer. Neoplasma 29, 669–674.
Schramm, U., Fleckenstein, W., and Weber, C. (1990) Morphological assessment of skeletal muscular injury caused by p02 measurements with hypodermic needle probes, in Clinical Oxygen Pressure Measurement II (Ehrly, A. M., Fleckenstein, W., Hauss, J., and Huch, R., eds.), Blackwell Ueberreuter Wissenschaft, Berlin, pp. 38–50.
Lartigau, E., Lespinasse, F., Vitu, L., and Guichard, M. (1992) Does the direct measurement of oxygen tension in tumours have any adverse effect? Int. J. Radiat. Oncol. Biol. Phys. 22, 949–951.
Khalili, A. A., Horsman, M. R., Nordsmark, M., Grau, C., and Overgaard, J. (1995) Oxygenation status in an experimental murine tumour system, in Tumor Oxygenation (Vaupel, P. W., ed.), Gustav Fischer Verlag, Stutgart, pp. 107–117.
Vaupel, P. W., Frinak, S., and Bicher, H. I. (1981) Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res. 41, 2008–2013.
Kallinowski, F., Zander, R., Höckel, M., and Vaupel, P. (1990) Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int. J. Radiat. Oncol. Biol. Phys. 19, 953–961.
Horsman, M. R., Hansen, P. V., and Overgaard, J. (1989) Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status. Int. J. Radiat. Oncol. Biol. Phys. 16, 1273–1276.
Simon, J. M., Lartigau, E., and Guichard, M. (1993) Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumors. Radiother. Oncol. 28, 203–207.
Thomas, C. D., Prade, M., and Guichard, M. (1995) Tumour oxygenation, radiosensitivity and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration. Int. J. Radiat. Biol. 67, 597–605.
Nozue, M., Lee, I., Yuan, F., Teicher, B. A., Brizel, D. M., Dewhirst, M. W., et al. (1997) Inter-laboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker. Surg. Oncol. 66, 30–38.
Vaupel, P. W. (1990) Oxygenation of human tumors. Stralenther. Onkol. 166, 377–386.
Lartigau, E., Vitu, L., Haie-Meder, C., Cosser, M. F., Delapierre, M., Gerbaulet, A., Eschwege, F., and Guichard, M. (1992) Feasibility of measuring oxygen tension in uterine cervix carcinoma. Eur. J. Cancer 28, 1354–1357.
Lartigau, E., Le Ridant, A. M., Lambin, P., Weeger, P., Martin, L., Sigal, R., et al. (1993) Oxygenation of head and neck tumors. Cancer 71, 2319–2325.
Lartigau, E., Randrianarivelo, H., Martin, L., Stern, S., Thomas, C. D., Guichard, M., et al. (1994) Oxygen tension measurements in human tumors: the Institut Gustave-Roussy Experience. Radiat. Oncol. Invest. 1, 285–291.
Fleckenstein, W., Jungblut, J. R., and Suckfull, M. (1990) Distribution ofoxygen pressure in the periphery and centre ofmalignant head and neck tumors, in Clinical Oxygen Pressure Measurement II (Ehrly, A. M., Fleckenstein, W., Hauss, J., and Huch, R., eds.), Blackwell Ueberreuter Wissenschaft, Berlin, pp. 81–90.
Nordsmark, M., Overgaard, M., and Overgaard, J. (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41, 31–39.
Terris, D. J. and Dunphy, E. P. (1994) Oxygen tension of head and neck cancers. Arch. Otolaryngol. Head Neck Surg. 120, 283–287.
Vaupel, P. W. and Höckel, M. (1995) Oxygenation status of human tumours: a reappraisal using computerized pO2 histography, in Tumor Oxygenation (Vaupel, P. W., Kelleher, D. K., and Gunderoth, M., eds.), Gustav Fischer Verlag, Stuttgart, pp. 219–232.
Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Baussmann, E., Mitze, M., Knapstein, P. G., and Vaupel, P. (1993) Intratumoral pO2 predicts survival in advanced cancer ofthe uterine cervix. Radiother. Oncol. 26, 45–50.
Höckel, M., Vorndran, B., Schlenger, K., Baussmann, E., and Knapstein, P. G. (1993) Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gyn. Oncol. 51, 141–149.
Wong, R. K. W., Fyles, A., Milosevic, M., Pintilie, M., and Hill, R. P. (1997) Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position and track depth. Int. J. Radiat. Oncol. Biol. Phys. 39, 405–412.
Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A., and Workman, P. (1994) Pretreatment oxygenation profiles of human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 29, 427–431.
Brizel, D. M., Rosner, G. L., Harrelson, J., Prosnitz, L. R., and Dewhirst, M. W. (1994) Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 30, 635–642.
Lusinchi, A., Lartigau, E., Luboinski, B., and Eschwege, F. (1994) Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. In. J. Radiat. Oncol. Biol. Phys. 29, 149–152.
Keresteci, Q. G. and Rider, M. B. (1973) Use oforthobaric oxygen in the radiotherapy ofbladder tumors. Can. J. Surg. 16, 127–129.
Rubin, P., Hanley, J., Keys, H. M., Marcial, V., and Brady, L. (1979) Carbogen breathing during radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 5, 1963–1970.
Henk, J. M. (1981) Does hyperbaric oxygen have a future in radiation therapy? Int. J. Radiat. Oncol. Biol. Phys. 7, 1125–1128.
Martin, L., Lartigau, E., Weeger, P., Lambin, P., Le Ridant, A. M., Lusinchi, A., et al. (1993) Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother. Oncol. 27,123–130.
Falk, S. J., Ward, R., and Bleehen, N. M. (1992) The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised pO2 histography. Br. J. Cancer 66, 919–924.
Brown, J. M. (1989) Hypoxic cells radiosensitizers: where next? Int. J. Radiat. Oncol. Biol. Phys. 16, 987–993.
Guichard, M. (1991) The use of fluorocarbon emulsions in cancer radiotherapy. Radiother. Oncol. 20(Suppl.), 59–64.
Dische, S. (1991) Radiotherapy and anaemia. The clinical experience. Radiother. Oncol. 20(Suppl.), 35–40.
Workman, P. and Stratford, I. J. (1993) The experimental development of bioreductive drugs and their role in cancer therapy. Cancer Metatesis Rev. 12, 73–82.
Brown, J. M. (1993) SR-4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumors. Br. J. Cancer 67, 1163–1170.
Lartigau, E. and Guichard, M. (1995) Does tirapazamine (SR-4233) have any cytotoxic or sensitising effect on 3 human cell lines at clinically relevant partial oxygen pressure? Int. J. Radiat. Biol. 2, 211–216.
Horsman, M. R. and Overgaard, J. (1997) Can mild hyperthermia improve tumour oxygenation? Int. J. Hyperthermia 13, 141–147.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lartigau, E., Guichard, M. (1999). Oxygenation of Solid Tumors in Animals and Patients. In: Teicher, B.A. (eds) Antiangiogenic Agents in Cancer Therapy. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-453-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-453-5_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4518-4
Online ISBN: 978-1-59259-453-5
eBook Packages: Springer Book Archive